Increased Expression of EZH2, a Polycomb Group Protein, in Bladder Carcinoma
- 1 October 2005
- journal article
- research article
- Published by S. Karger AG in Urologia Internationalis
- Vol. 75 (3), 252-257
- https://doi.org/10.1159/000087804
Abstract
Recent experiments have demonstrated that polycomb group gene enhancer zeste homolog 2 (EZH2) is highly expressed in many cancer types. Therefore, we aim to demonstrate EZH2 gene expression in transitional cell bladder cancer.The reverse transcriptase-polymerase chain reaction (RT-PCR) was used for detection of EZH2 mRNA levels in healthy and cancerous human bladder specimens. Also, expression of the particular protein was determined by Western blotting and immunohistochemistry to confirm RT-PCR results.Gradually increased expression of EZH2 was detected by mRNA and protein levels in highly advanced bladder cancer specimens. In contrast, 100% of control subjects were negative for EZH2 expression. The expression of EZH2 was more frequent in G3 (92%) than G1-G2 (62-63%) and more frequent in T1-2 (72-85%) than Ta (56%). Western blot analysis results confirm the RT-PCR results.EZH2 overexpression precedes high frequencies of proliferation and the gradual advance of bladder cancer. These observations suggest that deregulated expression of EZH2 is associated with bladder carcinoma.Keywords
This publication has 16 references indexed in Scilit:
- Activated p53 suppresses the histone methyltransferase EZH2 geneOncogene, 2004
- Genitourinary cancer in the elderlySeminars in Oncology, 2004
- Poorly Differentiated Breast Carcinoma is Associated with Increased Expression of the Human Polycomb Group EZH2 GeneNeoplasia, 2003
- EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancerThe EMBO Journal, 2003
- EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- The polycomb group protein EZH2 is involved in progression of prostate cancerNature, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Coexpression of BMI-1 and EZH2 Polycomb Group Genes in Reed-Sternberg Cells of Hodgkin’s DiseaseThe American Journal of Pathology, 2000
- The human EZH2 gene: genomic organisation and revised mapping in 7q35 within the critical region for malignant myeloid disordersEuropean Journal of Human Genetics, 2000
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976